Protocol

Calculating Antibody Dilution — Formulas and Worked Examples

Antibody dilution calculations use either the C1V1 = C2V2 formula (when working with known concentrations) or ratio-based serial dilution (when working with stock solutions specified by dilution factor).

Part of: Western Blot Protocols

Antibody dilution calculations use either the C1V1 = C2V2 formula (when working with known concentrations) or ratio-based serial dilution (when working with stock solutions specified by dilution factor). For example, a 1:1000 dilution of a 1 mg/mL antibody stock requires 1 µL antibody + 999 µL diluent, yielding a final concentration of 1 µg/mL. The method you choose depends on whether your antibody is provided as a concentration (e.g., 0.5 mg/mL) or a recommended working dilution (e.g., 1:500 for Western blot).

This guide provides the underlying formulas, worked examples for both concentration-based and ratio-based dilutions, and practical considerations for preparing primary and secondary antibody solutions in Western blot, immunohistochemistry, and immunofluorescence protocols. Examples use rabbit polyclonal antibodies typical of proteinase research applications, where target abundance varies widely depending on tissue type and induction state.

C1V1 = C2V2 Formula for Antibody Dilutions

The dilution equation C1V1 = C2V2 applies when you know the starting concentration (C1) and want to prepare a specific final concentration (C2) in a defined final volume (V2). Rearranging for V1 gives you the volume of stock antibody needed:

V1 = (C2 × V2) / C1

Where: C1 = initial antibody concentration, V1 = volume of stock to transfer, C2 = desired final concentration, V2 = total final volume.

Worked example: You have a rabbit polyclonal anti-MMP-9 antibody at 0.8 mg/mL and need 5 mL of a 2 µg/mL working solution for Western blot. First, convert units to match: C1 = 800 µg/mL, C2 = 2 µg/mL, V2 = 5 mL = 5000 µL. Then: V1 = (2 µg/mL × 5000 µL) / 800 µg/mL = 12.5 µL. Add 12.5 µL antibody stock to 4987.5 µL diluent (typically TBST + 5% non-fat milk or BSA).

This formula is most useful when working with purified antibodies provided at a known concentration, common for many research-grade polyclonals including those raised against recombinant proteinase domains.

Understanding Dilution Ratios (1:1000, 1:500, etc.)

A dilution ratio expresses the relationship between antibody volume and total final volume. A 1:1000 dilution means 1 part antibody in 1000 parts total, not 1 part antibody plus 1000 parts diluent. This is a frequent source of error.

For a 1:X dilution: antibody volume = total volume / X, and diluent volume = total volume - antibody volume.

Worked example (1:1000 dilution): To prepare 10 mL at 1:1000, antibody volume = 10,000 µL / 1000 = 10 µL. Diluent volume = 10,000 µL - 10 µL = 9990 µL. Combine 10 µL antibody with 9990 µL diluent.

Worked example (1:500 dilution): To prepare 3 mL at 1:500, antibody volume = 3000 µL / 500 = 6 µL. Diluent volume = 3000 µL - 6 µL = 2994 µL.

Most antibody datasheets for Western blot specify starting dilutions as ratios (e.g., 1:500 to 1:2000 for primary, 1:5000 to 1:10000 for HRP-conjugated secondary). These recommendations assume standard antigen abundance; MMP-2 or cathepsin D in tumor lysates may allow 1:2000 primary dilution, while low-abundance targets like ADAM-TS4 in normal tissue may require 1:500 or optimization to 1:250.

Converting Between Concentration and Dilution Ratio

If you know the stock concentration and the recommended dilution ratio, you can calculate the final working concentration, or vice versa. This is useful for comparing protocols or when switching between antibody lots with different stock concentrations.

Final concentration (C2) = Stock concentration (C1) / Dilution factor

Example: A rabbit anti-cathepsin L antibody is supplied at 1 mg/mL and the datasheet recommends 1:1000 for Western blot. Final working concentration = 1000 µg/mL / 1000 = 1 µg/mL.

Conversely, if you want to achieve a specific final concentration (e.g., 0.5 µg/mL) from a 0.8 mg/mL stock: Dilution factor = 800 µg/mL / 0.5 µg/mL = 1600. This corresponds to a 1:1600 dilution.

This conversion is particularly useful when a new antibody lot arrives at a different concentration. If your optimized protocol uses 1:1000 of a 1 mg/mL stock (= 1 µg/mL final), and the new lot is 0.6 mg/mL, you need 1:600 to achieve the same 1 µg/mL working concentration.

Serial Dilutions for Antibody Titration

Serial dilution is the standard method for antibody titration experiments, where you test multiple dilutions simultaneously to determine the optimal signal-to-noise ratio. A serial dilution involves repeatedly diluting a sample by a constant factor, typically 2-fold or 10-fold steps.

Two-fold serial dilution example: Starting from 1:500, a 4-step two-fold series gives 1:500, 1:1000, 1:2000, 1:4000. To prepare these in 1 mL volumes:

  • Tube 1 (1:500): 2 µL antibody + 998 µL diluent
  • Tube 2 (1:1000): Transfer 500 µL from Tube 1 + 500 µL fresh diluent
  • Tube 3 (1:2000): Transfer 500 µL from Tube 2 + 500 µL fresh diluent
  • Tube 4 (1:4000): Transfer 500 µL from Tube 3 + 500 µL fresh diluent

For titrating a new rabbit polyclonal against a proteinase target, start broader: test 1:250, 1:500, 1:1000, 1:2000 for Western blot, or 1:50, 1:100, 1:200, 1:400 for IHC. Gelatinase antibodies (MMP-2, MMP-9) often work at higher dilutions than less abundant targets like MT1-MMP or specific TIMP isoforms in non-induced cells.

Preparing Working Solutions for Multi-Sample Experiments

When processing multiple blots or slides, prepare a master mix of antibody solution to ensure consistency. Calculate total volume needed (volume per sample × number of samples) plus 10-20% overage to account for pipetting loss and dead volume in reservoirs.

Example: Running six Western blot membranes, each requiring 10 mL of 1:1000 primary antibody. Total needed = 6 × 10 mL = 60 mL, plus 15% overage = 69 mL. For 1:1000 dilution: 69 µL antibody + 68,931 µL blocking buffer (TBST with 5% BSA).

For rabbit polyclonals used in IHC on paraffin sections, volume per slide is typically 100-300 µL depending on section size and whether you use coverslip or humidified chamber incubation. A 24-slide experiment at 200 µL per slide with 1:100 primary dilution requires: 24 × 200 µL × 1.2 (overage) = 5.76 mL total, which needs 57.6 µL antibody + 5702.4 µL antibody diluent.

Prepare master mixes fresh for each experiment when possible. Most polyclonal antibodies in carrier protein (BSA or gelatin) maintain activity in diluted working solutions for 24-48 hours at 4°C, but repeated freeze-thaw of diluted solutions degrades performance.

Adjusting Dilutions Based on Detection Method

Optimal antibody dilution depends heavily on the detection system sensitivity and the abundance of your target proteinase. Chemiluminescent Western blot detection tolerates higher primary dilutions (1:1000 to 1:5000) than colorimetric methods (1:200 to 1:1000) due to signal amplification through HRP turnover. Enhanced chemiluminescence (ECL) substrates with extended femtogram sensitivity may permit 1:10,000 primary dilutions for abundant targets.

For immunohistochemistry, detection chemistry directly impacts antibody requirements:

  • DAB with HRP-polymer secondary: 1:100 to 1:500 primary dilution typical for formalin-fixed paraffin-embedded (FFPE) tissue
  • Fluorescent secondary (Alexa Fluor, etc.): 1:50 to 1:200 primary, as fluorescence is direct 1:1 labeling without enzymatic amplification
  • Tyramide signal amplification (TSA): 1:500 to 1:2000 primary, leveraging HRP-catalyzed fluorophore deposition

Proteinase expression varies substantially by tissue and disease state. MMP-9 in invasive tumor margins may be detectable at 1:2000, while the same antibody on normal colon requires 1:500. Cathepsin B in lysosome-rich kidney tubules tolerates higher dilutions than cathepsin B in fibroblasts.

Common Pitfalls

  • Confusing dilution ratio with parts diluent: A 1:1000 dilution requires 1 µL antibody + 999 µL buffer, not 1 µL + 1000 µL. The ratio includes the antibody volume in the denominator. This error results in 2-fold under-dilution and wastes antibody.
  • Mismatched concentration units: Mixing mg/mL with µg/mL in C1V1=C2V2 calculations produces 1000-fold errors. Always convert to common units before calculation. Stock antibodies are typically 0.5-2 mg/mL; working concentrations are usually 0.1-5 µg/mL.
  • Ignoring target abundance variation: Using the same 1:1000 dilution for MMP-9 in serum-stimulated fibroblasts and unstimulated controls leads to overexposure in induced samples or no signal in controls. Titrate antibodies for each experimental condition, especially in proteinase research where expression is highly inducible.
  • Inadequate master mix volume calculation: Forgetting to add overage for pipetting loss, especially with multichannel pipettes or reagent reservoirs, leaves insufficient volume for final samples. Add 15-20% overage for experiments beyond 8 samples.
  • Serial dilution carryover error: Reusing the same pipette tip during serial dilution transfers without accounting for carryover volume creates dilution inaccuracy. Use fresh tips for each transfer, or add a compensation factor for carryover when preparing very dilute solutions.
  • Assuming antibody concentration remains constant across lots: Different production lots may have 0.5 mg/mL versus 1.2 mg/mL concentration. Always verify concentration on the datasheet and recalculate dilutions when switching lots to maintain consistent working concentration.

References

  1. Mahmood T, Yang PC. Western blot: technique, theory, and trouble shooting. N Am J Med Sci. 2012;4(9):429-434.
  2. Ramos-Vara JA, Miller MA. When tissue antigens and antibodies get along: revisiting the technical aspects of immunohistochemistry—the red, brown, and blue technique. Vet Pathol. 2014;51(1):42-87.
  3. Lipman NS, Jackson LR, Trudel LJ, Weis-Garcia F. Monoclonal versus polyclonal antibodies: distinguishing characteristics, applications, and information resources. ILAR J. 2005;46(3):258-268.
  4. Bordeaux J, Welsh AW, Agarwal S, et al. Antibody validation. BioTechniques. 2010;48(3):197-209.
  5. Kurien BT, Scofield RH. Western Blotting: Methods and Protocols. Methods in Molecular Biology, Vol 536. Humana Press; 2009.